October 17, 2025 a 01:00 pm
ELV: Analysts Ratings - Elevance Health Inc.
Elevance Health Inc. continues to exhibit a robust performance in the health benefits sector, contributing significantly to the wellness of approximately 118 million individuals. Over recent months, the analyst ratings reflect a strong lean towards positive recommendations, indicative of the company's solid market positioning and operational stability. With diversification through medical, pharmacy, behavioral, and clinical solutions, Elevance Health maintains a consistent trajectory towards growth and market leadership.
Historical Stock Grades
In October 2025, the latest data reveal a positive analyst sentiment towards Elevance Health Inc. with the majority favoring "Buy" recommendations. The overall balance of opinions suggests confidence in the stock's potential and forward-looking growth. Below is a breakdown of the ratings and their respective scores.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 11 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the past several months, the analyst sentiment for Elevance Health Inc. has remained relatively stable, with a consistent preference for "Buy" ratings. The "Strong Buy" category has seen minor fluctuations, whereas the "Hold" recommendations have slightly increased.
- A decline in "Strong Buy" ratings is noticeable since mid-2024, albeit with consistent numbers in recent months.
- The "Hold" ratings have shown a slight upward trend.
- The total number of recommendations has remained stable, indicative of sustained interest and coverage by analysts.
Percentage Trends
Analyzing the percentage distribution of recommendations, Elevance Health Inc. demonstrates a shifting sentiment favoring "Hold" ratings more recently, possibly indicating a more cautious approach by analysts. From November 2024 to October 2025, the data indicate slight but noticeable changes in the distribution of opinions.
- The "Strong Buy" percentage has decreased from about 26% to 18%.
- The "Buy" ratings have maintained a strong presence but have slightly decreased in relative terms.
- "Hold" ratings have increased in percentage, suggesting a more balanced viewpoint.
- The most notable strength remains the absence of any significant "Sell" recommendations.
These shifts highlight a mix of sustained confidence and cautious optimism among analysts, with a general consensus leaning towards continuing investment but with a watchful eye on future developments.
Latest Analyst Recommendations
Recent analyst actions reflect consistent sentiment with no significant downgrades or upgrades. The latest recommendations indicate a steady state of views among key players, reinforcing a general consensus on maintaining current ratings.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-14 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-10-10 | Neutral | Neutral | B of A Securities |
| 2025-10-09 | Overweight | Overweight | Barclays |
| 2025-10-09 | Outperform | Outperform | Mizuho |
| 2025-10-08 | Buy | Buy | Guggenheim |
Analyst Recommendations with Change of Opinion
Analysts have adjusted their stance on Elevance Health Inc. over the past few months, reflecting nuanced perspectives in light of market conditions and company performance. Although some downgrades have occurred, they do not overshadow the prevailing positive outlook.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-21 | Hold | Buy | Argus Research |
| 2025-07-18 | Market Perform | Outperform | Leerink Partners |
| 2025-04-15 | Neutral | Outperform | Baird |
| 2025-03-17 | Buy | Hold | Argus Research |
| 2024-10-18 | Hold | Buy | Argus Research |
Interpretation
The overall analyst sentiment towards Elevance Health Inc. illustrates a stable outlook with a primary focus on extended "Buy" ratings. While there is a moderated increase in "Hold" recommendations, the general consensus underscores confidence in the company's market strategies and growth potential. The absence of "Sell" ratings signals entrenched trust in the company's trajectory. Despite some cautionary updates, the sentiment remains resilient, reflecting balanced optimism and strategic prudence among analysts.
Conclusion
Elevance Health Inc. stands in a favorable position within the health benefits sector, supported by a diverse range of solution offerings and a strong market presence. The analyst sentiment, largely "Buy" oriented, indicates positive expectations for continued performance, albeit with mindful attention to shifts in the industry landscape. The steadiness in ratings and absence of negative sentiment highlight potential opportunities for growth, while the slight rise in "Hold" ratings suggests caution amidst sector-specific dynamics. Collectively, the insights point toward a watchful yet optimistic future for Elevance Health as it navigates through competitive landscapes and sector advancements.